HLA Expression by Benign and Malignant Prostatic Epithelium: Augmentation by Interferon-Gamma
Author:
Affiliation:
1. From the Departments of Anatomic Pathology and Urology and the Center for Immunochemistry, Department of Veteran Affairs Medical Center and the Departments of Pathology, Laboratory Medicine, and Urology, University of California, San Francisco
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference22 articles.
1. Incidental lymphocytic prostatitis: selective involvement with nonmalignant glands;Blumenfeld;Am. J. Surg. Pathol.,1992
2. Histocompatibility antigens on murine tumors;Goodenow;Science,1985
3. Selective changes in expression of HLA class I polymorphic determinants in human solid tumors;Natali;Proc. Natl. Acad. Sci. USA,1989
4. Role of major histocompatibility complex class I antigens in tumor growth and metastasis;Tanaka;Ann. Rev. Immunol.,1988
5. The influence of major histocompatibility complex class I antigens on tumor growth and metastasis;Hammerling;Biochim. Biophys. Acta,1987
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The effect of human leukocyte antigen genotype on survival in advanced prostate cancer treated with primary androgen deprivation therapy: the KYUCOG-1401-A study;Prostate Cancer and Prostatic Diseases;2024-02-17
2. The Prostate Cancer Immune Microenvironment, Biomarkers and Therapeutic Intervention;Uro;2022-04-10
3. MHC class I and class II molecules are expressed in both human and mouse prostate tumor microenvironment;The Prostate;2006-06-01
4. The aberrant expression of HLA-DR in intrahepatic bile ducts in patients with biliary atresia: An immunohistochemistry and immune electron microscopy study;Journal of Pediatric Surgery;2004-11
5. Loss of CD38 correlates with simultaneous up-regulation of human leukocyte antigen-DR in benign prostatic glands, but not in fetal or androgen-ablated glands, and is strongly related to gland atrophy;BJU International;2003-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3